Empowering Discovery and Development of Bispecific ADCs With a Common Light Chain Antibody Library and a Novel Linker/Payload_Biocytogen Pharmaceuticals (Beijing) Co., Ltd._Empowering,Discovery,and,Development,of,Bispecific,ADCs,With,a,Common,Light,Chain,Antibody,Library,and,a,Novel,Linker,Payload

top

Please input keywords

KR

사회적 책임

합작연구개발

Antibody Assets

Project Integrum

Antibody discovery platforms

Clinical pipeline

Preclinical pipeline

동물/세포 모델

Pharmacology service

유전자 편집

Stock Information

Financial Reports

Listing Documents

Announcements & Notices

Corporate Governance

Investor Calendar

Empowering Discovery and Development of Bispecific ADCs With a Common Light Chain Antibody Library and a Novel Linker/Payload

2024.04.26

Prev:Maximize Your Drug Design Poss...

Next:None